Benefits of thromboelastometry for monitoring replacement therapy in patients with severe inherited factor XIII deficiency: 3 illustrative cases

Haemophilia. 2019 Sep;25(5):e336-e338. doi: 10.1111/hae.13823. Epub 2019 Jul 30.

Authors

Séverine Bouttefroy¹, Sandrine Meunier¹, Emilie Jousselme², Lucia Rugeri¹

Affiliations

¹ Hospices Civils de Lyon, Unité d'Hémostase Clinique/Centre Régional de Traitement de l'Hémophilie, Hôpital Louis Pradel, Bron, France.
² Laboratoire d'Hémostase, Centre de Biologie et de Pathologie Est, Hospices Civils de Lyon, Lyon, France.

PMID: 31361371
DOI: 10.1111/hae.13823

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Factor XIII / pharmacology
Factor XIII / therapeutic use*
Factor XIII Deficiency / drug therapy*
Female
Humans
Infant
Infant, Newborn
Male
Thrombelastography / methods*

Substances

Factor XIII